Dr Riyaz Shah· @DrRiyazShah · X·· 14 小时前评分70
正文 · 原文
DeLLphi-305; ES-SCLC; nearly 2y mOS; Strong PFS signal; this is about the strongest data I’ve seen in this space. @BTOGORG #ESMO26
122 浏览 · 2 赞 · 0 转发 · 1 回复
会议摘要
LBA3按 Presidential Symposium I 对上
Tarlatamab plus durvalumab (durva) vs durva as 1L maintenance (1LM) therapy following durva, platinum, and etoposide (1L durva + EP) in extensive-stage small cell lung cancer (ES-SCLC): Primary analysis of the phase 3 DeLLphi-305 trial
https://esmocongress.esmo.org帖内回复
- Dr Riyaz Shah@DrRiyazShah
Standing ovation….. like a Mexican wave, industry staffers initiated? But to be fair it’s great data #ESMO26
来源：Dr Riyaz Shah · x.com